Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Vaccines and Immunization Policy stories

Sep 8, 2026

FDA Approves First mRNA Flu Vaccine for Adults 50 and Older

Moderna's mFLUSIVA becomes the first mRNA-based seasonal influenza vaccine to receive FDA approval.

Sep 8, 2026·4 sources
00

Top claims

  • ▪mRNA flu vaccines will prove more effective than traditional flu shots at preventing seasonal influenza
  • ▪FDA approved Moderna's mFLUSIVA on August 5, 2026, the first mRNA-based seasonal influenza vaccine
  • ▪The vaccine is approved for adults 50 and older, the age group that accounts for most flu deaths

Subtopics

Drug Approval and Clinical Trials1Drug Policy, Pricing & Approval1mRNA Flu Vaccine Approval 20261Vaccine development and innovation1Vaccines and Immunization Policy1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Ebola outbreak

85 stories

Iran War

209 stories

Russia-Ukraine war

136 stories